doz-zabudova.ru


89 bio stock

89bio, Inc.'s latest quarterly earnings per share is $ with a past EPS surprise of $ The latest EPS estimate is $ Read more about 89bio, Inc.'s. A break-up at the top trend line at $ will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise. 89bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of.

89bio, Inc. Stock price ; Mean consensus. BUY ; Number of Analysts. 10 ; Last Close Price. USD ; Average target price. USD ; Spread / Average Target. +. Analyst Forecast. According to 8 analysts, the average rating for ETNB stock is "Strong Buy." The month stock price forecast is $, which is an increase. Stock analysis for 89bio Inc (ETNB:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

89bio Inc. ; 12 Month Change. % ; Day Range - ; 52 Wk Range - ; Volume, M ; Market Value, $B. Today's High; $ Today's Low; $ 52 Week High; $ 52 Week Low; $ Data Provided by Refinitiv. Minimum 15 minutes delayed. 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and.

89bio, Inc.'s (NASDAQ:ETNB) one-year returns climbed after last week's % gain, institutional investors must be happy. Key Insights Significantly high.Latest 89Bio Inc (ETNB:NMQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.Get 89Bio Inc (ETNB:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

89bio Inc. (ETNB) PT Raised to $49 at Evercore ISIEvercore ISI analyst Liisa Bayko raised the price target on 89bio Inc. (NASDAQ: ETNB) to $ (from $). Key Data ; 52 Week High/Low, $/$ ; Market Cap, 1,,, ; Forward P/E 1 Yr. ; Earnings Per Share(EPS), $ ; Annualized Dividend, N/A. ETNB | Complete 89bio Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. On average, Wall Street analysts predict that 89bio's share price could reach $ by Mar 7, The average 89bio stock price prediction forecasts a.

ETNB Related stocks ; ETNB, +%. 89Bio Inc ; AMGN, +%. Amgen Inc ; VRTX, +%. Vertex Pharmaceutic ; REGN, +%. Regeneron Pharmaceuticals ; BMY, + Based on the analysis of 89bio's profitability, liquidity, and operating efficiency, 89bio Inc is not in a good financial situation at this time. It has a very. 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and. On Monday 01/08/ the closing price of the 89bio Inc Registered Shs share was $ on BTT. Compared to the opening price on Monday 01/08/ on BTT of. SAN FRANCISCO, March 05, (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and.

PROFILE (ETNB). 89bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of innovative therapies for. Track 89bio Inc (ETNB) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable. Track 89bio Inc (ETNB) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable. According to analysts, 89bio's stock has a predicted upside of % based on their month stock forecasts. What analysts cover 89bio? 89bio has been rated.


Copyright 2016-2024 Privice Policy Contacts SiteMap RSS